Clinical Trial Update: A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]

View source ↗

Summary

Phase 3 trial of atezolizumab with carboplatin and nab-paclitaxel vs carboplatin and nab-paclitaxel in stage IV non-squamous non-small cell lung cancer complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Non-squamous Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Non-Squamous Non-Small Cell Lung | Phase 3 | Status: COMPLETED | Results posted: 2019-04-03